KALA BIO, Inc.
Support and Resistance Levels
Past performance
News About KALA
All events for KALA
All deals for KALA
Financial Ratios
Financial Statements
KALA vs Sector & Peers
About KALA BIO, Inc.
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts. Website kalarx.com
Headquarters Arlington, MA, US